Macquarie Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.7M | Sell |
36,707
-20,577
| -36% | -$6.76M | 0.06% | 227 |
|
|
2025
Q4 | $20.1M | Sell |
57,284
-73,788
| -56% | -$24.9M | 0.09% | 180 |
|
|
2025
Q3 | $42.4M | Sell |
131,072
-12,400
| -9% | -$3.86M | 0.05% | 471 |
|
|
2025
Q2 | $55.8M | Buy |
143,472
+5,777
| +4% | +$2.32M | 0.07% | 393 |
|
|
2025
Q1 | $59.9M | Buy |
137,695
+11,686
| +9% | +$4.69M | 0.07% | 359 |
|
|
2024
Q4 | $43.2M | Sell |
126,009
-40,189
| -24% | -$16.8M | 0.05% | 459 |
|
|
2024
Q3 | $86.4M | Buy |
166,198
+57,376
| +53% | +$30.7M | 0.09% | 294 |
|
|
2024
Q2 | $59M | Buy |
108,822
+6,290
| +6% | +$3.32M | 0.07% | 374 |
|
|
2024
Q1 | $53.2M | Sell |
102,532
-29,284
| -22% | -$14.6M | 0.06% | 417 |
|
|
2023
Q4 | $62.2M | Buy |
131,816
+51,958
| +65% | +$24M | 0.07% | 371 |
|
|
2023
Q3 | $34.8M | Buy |
79,858
+1,630
| +2% | +$739K | 0.04% | 512 |
|
|
2023
Q2 | $34.8M | Sell |
78,228
-35,438
| -31% | -$16.3M | 0.04% | 541 |
|
|
2023
Q1 | $52.3M | Sell |
113,666
-89,214
| -44% | -$42.5M | 0.06% | 409 |
|
|
2022
Q4 | $104M | Sell |
202,880
-15,245
| -7% | -$7.74M | 0.12% | 230 |
|
|
2022
Q3 | $99.1M | Sell |
218,125
-11,121
| -5% | -$5.32M | 0.12% | 228 |
|
|
2022
Q2 | $111M | Sell |
229,246
-95,978
| -30% | -$47.5M | 0.12% | 218 |
|
|
2022
Q1 | $160K | Sell |
325,224
-18,003
| -5% | -$8.23M | 0.12% | 185 |
|
|
2021
Q4 | $159M | Sell |
343,227
-152,835
| -31% | -$64.3M | 0.13% | 202 |
|
|
2021
Q3 | $185M | Sell |
496,062
-6,683
| -1% | -$2.54M | 0.16% | 152 |
|
|
2021
Q2 | $192M | Buy |
502,745
+380,915
| +313% | +$146M | 0.16% | 149 |
|
|
2021
Q1 | $43.7M | Sell |
121,830
-4,444
| -4% | -$1.43M | 0.06% | 362 |
|
|
2020
Q4 | $40.5M | Sell |
126,274
-2,608
| -2% | -$800K | 0.06% | 354 |
|
|
2020
Q3 | $34.6M | Buy |
128,882
+19,627
| +18% | +$5.28M | 0.06% | 342 |
|
|
2020
Q2 | $28.7M | Buy |
109,255
+17,252
| +19% | +$4.6M | 0.05% | 386 |
|
|
2020
Q1 | $20.9M | Buy |
92,003
+3,144
| +4% | +$857K | 0.04% | 405 |
|
|
2019
Q4 | $26.8M | Buy |
88,859
+1,133
| +1% | +$312K | 0.04% | 433 |
|
|
2019
Q3 | $21.1M | Buy |
87,726
+13
| +0% | +$3.56K | 0.04% | 437 |
|
|
2019
Q2 | $24.8M | Sell |
87,713
-12,454
| -12% | -$3.4M | 0.04% | 409 |
|
|
2019
Q1 | $28.7M | Sell |
100,167
-2,973
| -3% | -$860K | 0.05% | 384 |
|
|
2018
Q4 | $27.1M | Sell |
103,140
-1,120
| -1% | -$308K | 0.05% | 355 |
|
|
2018
Q3 | $28.6M | Sell |
104,260
-2,160
| -2% | -$561K | 0.05% | 395 |
|
|
2018
Q2 | $25.3M | Buy |
106,420
+500
| +0.5% | +$116K | 0.04% | 429 |
|
|
2018
Q1 | $23.3M | Buy |
105,920
+16,820
| +19% | +$3.95M | 0.04% | 428 |
|
|
2017
Q4 | $19.9M | Buy |
89,100
+7,400
| +9% | +$1.58M | 0.04% | 479 |
|
|
2017
Q3 | $15.5M | Buy |
81,700
+15,300
| +23% | +$2.91M | 0.03% | 510 |
|
|
2017
Q2 | $12.5M | Hold |
66,400
| – | – | 0.02% | 557 |
|
|
2017
Q1 | $11M | Sell |
66,400
-3,900
| -6% | -$620K | 0.02% | 594 |
|
|
2016
Q4 | $10.1M | Sell |
70,300
-35,800
| -34% | -$4.79M | 0.02% | 606 |
|
|
2016
Q3 | $13.3M | Sell |
106,100
-156,500
| -60% | -$20.2M | 0.03% | 532 |
|
|
2016
Q2 | $34.5M | Buy |
262,600
+112,000
| +74% | +$15.3M | 0.03% | 421 |
|
|
2016
Q1 | $20.9M | Sell |
150,600
-18,830
| -11% | -$2.52M | 0.04% | 339 |
|
|
2015
Q4 | $23.6M | Buy |
169,430
+7,930
| +5% | +$1.09M | 0.05% | 310 |
|
|
2015
Q3 | $22.6M | Buy |
161,500
+16,300
| +11% | +$2.45M | 0.05% | 314 |
|
|
2015
Q2 | $23.8M | Buy |
145,200
+22,586
| +18% | +$3.61M | 0.05% | 328 |
|
|
2015
Q1 | $18.9M | Buy |
122,614
+14,825
| +14% | +$2.11M | 0.04% | 384 |
|
|
2014
Q4 | $13.5M | Sell |
107,789
-12,211
| -10% | -$1.51M | 0.03% | 457 |
|
|
2014
Q3 | $14.4M | Sell |
120,000
-84,500
| -41% | -$9.69M | 0.03% | 437 |
|
|
2014
Q2 | $22M | Sell |
204,500
-22,900
| -10% | -$2.36M | 0.05% | 342 |
|
|
2014
Q1 | $22.6M | Buy |
227,400
+2,900
| +1% | +$262K | 0.04% | 318 |
|
|
2013
Q4 | $20.7M | Buy |
224,500
+3,867
| +2% | +$344K | 0.04% | 326 |
|
|
2013
Q3 | $18.4M | Buy |
220,633
+93,433
| +73% | +$8.01M | 0.04% | 339 |
|
|
2013
Q2 | $10.4M | Buy |
+127,200
| New | +$9.52M | 0.02% | 431 |
|
Other funds holding ELV
VCM
VPM
Macquarie Group's ELV Position: Q1 2026 in Review
Macquarie Group reduced its Elevance Health (ELV) stake by 36% in Q1 2026, selling an estimated $6.76M and leaving 36,707 shares worth $10.7M. The position accounts for 0.06% of the portfolio, ranked #227.
Macquarie Group first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $192M in Q2 2021. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Macquarie Group held 36,707 shares of Elevance Health worth $10.7M as of Q1 2026.
- Macquarie Group sold 20,577 Elevance Health shares in Q1 2026, an estimated $6.76M.
- Elevance Health made up 0.06% of Macquarie Group's portfolio in Q1 2026, its #227 holding.
- Macquarie Group first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Macquarie Group's Elevance Health position peaked at $192M in Q2 2021.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Macquarie Group's 13F filing for Q1 2026, filed 15 May 2026.